Literature DB >> 11338097

MRI of primary non-Hodgkin's lymphoma of the palatine tonsil.

A D King1, K I Lei, A T Ahuja.   

Abstract

Non-Hodgkin's lymphoma (NHL) arising primarily in the palatine tonsil is uncommon. The aims of the study were to describe the appearances on MRI and to identify the features that help to distinguish NHL from other tonsillar tumours. The clinical records and MR images of eight patients with primary NHL of the palatine tonsil were reviewed. Patients had a short duration of symptoms (mean 1 month). Systemic symptoms (fever, weight loss or night sweats) occurred in two patients. Tumours were round or lobulated and ranged in size from 30 mm to 70 mm. The signal intensity on T2 weighted, T1 weighted and T1 weighted contrast enhanced images was homogeneous and similar to that of normal tonsil in six patients. Two large tumours were mildly heterogeneous and one of these showed small foci of necrosis. NHL of the tonsil displaced rather than invaded local structures in seven patients and locally invaded the soft palate in only one patient. Lymphadenopathy was present in five patients and the nodes were of similar signal intensity to the primary tumour. There was involvement of the ipsilateral upper internal jugular chain in all cases of lymphadenopathy. The posterior triangle was involved in two patients, the periparotid node in one patient and the retro-oropharyngeal region in one patient. The presence of a large tumour without deep invasion together with homogeneous non-necrotic nodes suggests the diagnosis of NHL. As NHL frequently has similar signal intensity to normal tonsil, MRI may not be able to detect lymphomatous involvement in the non-enlarged tonsil.

Entities:  

Mesh:

Year:  2001        PMID: 11338097     DOI: 10.1259/bjr.74.879.740226

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

1.  Prognostic CT and MR imaging features in patients with untreated extranodal non-Hodgkin lymphoma of the head and neck region.

Authors:  Cuiping Zhou; Xiaohui Duan; Bowen Lan; Junjie Liao; Jun Shen
Journal:  Eur Radiol       Date:  2015-03-26       Impact factor: 5.315

2.  MRI of diffuse large B-cell non-Hodgkin's lymphoma of the head and neck: comparison of Waldeyer's ring and sinonasal lymphoma.

Authors:  Ann D King; Benjamin King Hong Law; Wai Kiu Tang; Frankie Kwok Fai Mo; Radha Raghupathy; Kunwar S Bhatia; Kenny I K Lei
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

3.  Imaging characteristics of primary laryngeal lymphoma.

Authors:  N A Siddiqui; Barton F Branstetter; B E Hamilton; L E Ginsberg; C M Glastonbury; H R Harnsberger; E L Barnes; E N Myers
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

Review 4.  Primary gastrointestinal lymphoma.

Authors:  Prasanna Ghimire; Guang-Yao Wu; Ling Zhu
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

5.  Non-Hodgkin lymphoma of the larynx: CT and MR imaging findings.

Authors:  Ann D King; Edmund H Y Yuen; Kenny I K Lei; Anil T Ahuja; Andrew Van Hasselt
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

6.  Optical coherence tomography and autofluorescence imaging of human tonsil.

Authors:  Hamid Pahlevaninezhad; Anthony M D Lee; Miriam Rosin; Ivan Sun; Lewei Zhang; Mehrnoush Hakimi; Calum MacAulay; Pierre M Lane
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

7.  Extranodal involvement in lymphoma - A Pictorial Essay and Retrospective Analysis of 281 PET/CT studies.

Authors:  Jayanta Das; Soumendranath Ray; Saugata Sen; Mammen Chandy
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

8.  The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies.

Authors:  Noriyuki Fujima; Akihiro Homma; Taisuke Harada; Yukie Shimizu; Khin Khin Tha; Satoshi Kano; Takatsugu Mizumachi; Ruijiang Li; Kohsuke Kudo; Hiroki Shirato
Journal:  Cancer Imaging       Date:  2019-02-04       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.